Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice

• Main Authors: Rui Fan (Author), Yao Wang (Author), Jinjin Zhang (Author), Xiangbo An (Author), Shuang Liu (Author), Jie Bai (Author), Jiatian Li (Author), Qiuyue Lin (Author), Yunpeng Xie (Author), Jiawei Liao (Author), Yunlong Xia (Author)
• Format: Book
• Published: MDPI AG, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Doxorubicin, a widely used chemotherapeutic drug in clinical oncology, causes a series of cardiac side effects referred to as doxorubicin-induced cardiotoxicity. Hyperhomocysteinaemia is an independent risk factor for multiple cardiovascular diseases. However, whether hyperhomocysteinaemia contribut...